Your browser doesn't support javascript.
loading
Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.
Jackson, William C; Desai, Neil B; Abugharib, Ahmed E; Tumati, Vasu; Dess, Robert T; Lee, Jae Y; Zhao, Shuang G; Soliman, Moaaz; Folkert, Michael; Laine, Aaron; Hannan, Raquibul; Zumsteg, Zachary S; Sandler, Howard; Hamstra, Daniel A; Montgomery, Jeffrey S; Miller, David C; Kozminski, Mike A; Hollenbeck, Brent K; Hearn, Jason W; Palapattu, Ganesh; Tomlins, Scott A; Mehra, Rohit; Morgan, Todd M; Feng, Felix Y; Spratt, Daniel E.
Afiliação
  • Jackson WC; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Desai NB; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Abugharib AE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Tumati V; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Lee JY; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Zhao SG; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Soliman M; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Folkert M; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Laine A; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Hannan R; Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA.
  • Zumsteg ZS; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Sandler H; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Hamstra DA; The Texas Center for Proton Therapy, Irving, TX, USA.
  • Montgomery JS; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
  • Miller DC; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
  • Kozminski MA; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
  • Hollenbeck BK; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
  • Hearn JW; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Palapattu G; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
  • Tomlins SA; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Mehra R; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Morgan TM; Department of Urology, University of Michigan, Ann Arbor, MI, USA.
  • Feng FY; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Spratt DE; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
BJU Int ; 120(3): 351-357, 2017 09.
Article em En | MEDLINE | ID: mdl-28139024
ABSTRACT

OBJECTIVES:

To characterise the frequency and detailed anatomical sites of failure for patients receiving post-radical prostatectomy (RP) salvage radiation therapy (SRT). PATIENTS AND

METHODS:

A multi-institutional retrospective study was performed on 574 men who underwent SRT between 1986 and 2013. Anatomical recurrence patterns were classified as lymphotrophic (lymph nodes only), osteotrophic (bone only), or multifocal if both were present. Isolated first failure sites were defined as sites of initial clinically detected recurrence that remained isolated for at least 3 months.

RESULTS:

The median follow-up after SRT was 6.8 years. The 8-year rates of local, regional, and distant failure for patients undergoing SRT were 2%, 6%, and 21%, respectively. Of the 22% men (128 of 574) who developed a clinically detectable recurrence, 17%, 50%, and 31% were lymphotrophic, osteotrophic, and multifocal, respectively. The trophic nature of metastases was prognostic for distant metastases-free survival (DMFS) and prostate cancer-specific survival (PCSS); the 10-year rates of DMFS were 18%, 5%, and 7% (P < 0.01), and PCSS were 78%, 68%, and 56% (P < 0.01), for lymphotrophic, osteotrophic, and multifocal failure patterns, respectively.

CONCLUSIONS:

We demonstrate that trophism for metastatic site has significant prognostic impact on PCSS in men treated with SRT. Radiographic local failure is an uncommon event after SRT when compared to historical data of patients treated with surgery monotherapy. However, distant failure remains a challenge in this patient population and warrants further therapeutic investigation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2017 Tipo de documento: Article